• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    More On AKR.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Akers Biosciences Inc. (AKR.L)

    -LSE
    240.00 Up 2.50(1.05%) 5:21AM EST
    Add to Portfolio
    Prev Close:237.50
    Open:239.00
    Bid:232.00
    Ask:260.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:239.00 - 255.80
    52wk Range:195.00 - 395.50
    Volume:1,903
    Avg Vol (3m):3,092
    Market Cap:11.89M
    P/E (ttm):N/A
    EPS (ttm):-0.76
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):331.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.45
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Akers Biosciences, Inc., together with its subsidiaries, focuses on the development and sale of disposable diagnostic testing devices to facilitate time sensitive therapeutic decisions in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback